Advanced Search

 

Study ID Status Title Patient Level Data
IPR109764 Completed A randomised, open, placebo-controlled 5-way crossover trial of single doses of intranasal GSK256066 in subjects with seasonal allergic rhinitis (SAR).
IPR110723 Completed An 8 day, randomised, double blind, 3-way crossover trial of repeat doses of intranasal GSK256066 and fluticasone propionate in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
IPR110982 Completed A randomised, double blind, 2-way crossover trial of 8 days repeat dosing with intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR)
ISO105774 Completed Single-blind, placebo-controlled, randomized study testing single ascending doses of GSK369796 in healthy subjects
ITI101711 Completed A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism following Total Knee Replacement Surgery
ITZ111682 Completed A Single Dose, Randomized Study to Assess the Relative Bioavailability of Two Formulations and Food Effect on GSK1265744 in Healthy Male and Female Subjects
ITZ111839 Completed A Phase I, open label crossover study to evaluate the effect of etravirine on GSK1265744 pharmacokinetics in healthy adult subjects (ITZ111839)
K91-007 Completed To compare the bioavailabilities of the clinical trial and production formulations of ondansetron tablets (8 mg) for post-operative nausea and vomiting.
KG2104940 Completed A double-blind, randomized, placebo-controlled, repeat dose study to compare the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK189075 with GW869682 in subjects with type 2 diabetes mellitus
KG2105255 Completed A Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment Naïve Subjects.
KG2110243 Completed A Two-Week, Randomized, Double-Blind, Repeat-Dose, Parallel-Group Study to Evaluate the Safety and Tolerability of Metformin > 2000mg Co-Administered with Either GSK189075 500mg BID or GSK 189075 750mg BID to Subjects with Type 2 Diabetes Mellitus
KG2110375 Completed A Once-Daily Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment-Naïve Subjects
KGW108201 Completed An exploratory study to evaluate weight loss, body composition changes, food intake and urine glucose excretion in healthy obese subjects over 8 weeks of dosing with GSK189075, GW869682 versus placebo
KGW111083 Completed A double-blind, randomized, 6-sequence, 3-period crossover drug-drug interaction study to evaluate the pharmacokinetics of WELLBUTRIN SR (bupropion) and GSK189075 when co-administered or administered alone in healthy male volunteers
KSP10014 Completed A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination with Carboplatin on an Every 21-Day Schedule in Subjects with Advanced Solid Tumors.
L_8598 Completed Fondaparinux sodium in ORthopaedic SurgEry (FORSE): A Prospective Evaluation of ArixtraTM for the Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery
L8405 Completed A multi-centre, randomised, open-label, parallel group, comparative study of the efficacy and safety of once daily fondaparinux 2.5mg versus fondaparinux 2.5mg plus graduated compression stockings for the prevention of venous thromboembolism in patients undergoing elective or emergency hip surgery
L8518 Completed Flexibility in administration of Arixtra for prevention of symptomatic venous thromboembolism in orthopedic surgery
L-8541 Completed Arixtra VTE Prevention Study - Fondaparinux compared with enoxaparin in the prevention of venous thromboembolism (VTE) in Chinese patients undergoing elective knee replacement, hip surgery or a revision of components.
L-8635 Completed Fondaparinux compared with enoxaparin in the prevention of venous thromboembolism in Taiwanese patients undergoing elective knee replacement.
LAM100034 Completed A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Partial Seizures Study Listed on ClinicalStudyDataRequest.com
LAM100036 Completed A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures Study Listed on ClinicalStudyDataRequest.com
LAM10004 Completed An open, randomised, parallel group study in healthy, young, male and female volunteers to evaluate the pharmacokinetic characteristics of single oral does of new LAMICTAL™ formulations. Study Listed on ClinicalStudyDataRequest.com
LAM10005 Completed A two-part, open label study in healthy, young, male and female volunteers to evaluate the pharmacokinetic characteristics of single and repeat oral doses of Lamictal SR/XR prototype formulations and to study the effects of food on pharmacokinetic parameters. Study Listed on ClinicalStudyDataRequest.com
LAM10007 Completed An open, randomised, study to investigate the gastrointestinal absorption (of 50 mg single doses) of lamotrigine from small bowel and ascending colon in healthy, male volunteers.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.